Thank you for registering your interest in our dry eye clinical trial. A member of the research team will be in touch within 2 business days to discuss the study with you.
What is the study for?
This study is assessing whether an experimental new eye ointment can improve the symptoms of dry eye caused by meibomian gland dysfunction.
The study is a Phase IIa clinical trial.
- 6 visits to our Sippy Downs centre over an approximately 3 ½ month period
- Medical and optical assessments
- Blood tests at two visits
- A 2-week run-in period using placebo
- Self-administration of the study ointment to your eyelid over a 3 month treatment period
The study treatment is an ointment applied to your lower eyelids just before bedtime.
This is a placebo controlled and double blinded study, which means you won't know whether you receive the vaccine or placebo, and nor will study staff.
The research team will sit down with you and go through the study criteria, as well as your medical history, ocular history, and current and past medications. There will be some blood tests as well as medical and optical examinations to help determine your eligibility for the study.
You will be required to present a valid form of ID at each visit.
All study procedures are at no cost to you, and you will be compensated for your time and travel expenses.
Where can I find more information?
More information can be requested by contacting the research site to the right. Alternatively, the research team will be more than happy to answer any questions you may have when they call.
You can also find more study information on the clinical trials database, ClinicalTrials.gov
HREC approval: St Vincent's HREC